SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-029838
Filing Date
2020-06-19
Accepted
2020-06-18 20:22:46
Documents
6
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200618.htm 6-K 24607
2 EX-99.1 lmnl-ex991_7.htm EX-99.1 44166
3 EX-99.2 lmnl-ex992_8.htm EX-99.2 9322
4 GRAPHIC gti5dgwfevsj000001.jpg GRAPHIC 50501
5 GRAPHIC gti5dgwfevsj000003.jpg GRAPHIC 7676
6 GRAPHIC gti5dgwfevsj000002.jpg GRAPHIC 1790
  Complete submission text file 0001564590-20-029838.txt   162269
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 20973960
SIC: 2834 Pharmaceutical Preparations